Cytokine profiles in early rejection following OKT3 treatment in liver transplant patients

• Prif Awduron: Sasan Roayaie (Awdur), Patricia A. Sheiner (Awdur), Sukru Emre (Awdur), Steven Guy (Awdur), Myron E. Schwartz (Awdur), Peter Boros (Awdur), Charles M. Miller (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Hindawi Limited, 2000-01-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

OKT3, a murine monoclonal antibody specific to the human CD3 complex, induces immunosuppression by depletion of T cells. Administration of OKT3 results in significant release of proinflammatory cytokines, such as TNFα and IL1β. Liver recipients who experience rejection within 3 weeks after transplan...